Clinical Trial
Candicidin for vaginal candidiasis
- PMID: 4567568
Item in Clipboard
Clinical Trial
Candicidin for vaginal candidiasis
Med Lett Drugs Ther.
.
Abstract
PIP: Candicidin for treatment of vaginal candidiasis is discussed. Candicidin has not been established as being superior to nystatin for cure or relief of monilial vaginal infections. Since nystatin has been in use for years with only minor adverse affect and since it is less exp ensive than candicidin, it should still be the drug of choice. If 1 or 2 courses of intravaginal and oral nystatin fail to cure (as tested by culture), candicidin is worth trying. Unlike mystatin, candicidin is not available in an oral formulation. Many "Medical Letter" consultants believe that cur of vaginal candidiasis is easier if patients stop taking oral contraceptives when the diagnosis is made.